These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19032227)

  • 21. Induction type and outcomes for kidney graft and patient survival in recipients with prior lung transplantation in the United States.
    Riad S; Goswami U; Jackson S; Hertz M; Matas A
    J Heart Lung Transplant; 2020 Feb; 39(2):157-164. PubMed ID: 31837899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
    Matignon M; Muthukumar T; Seshan SV; Suthanthiran M; Hartono C
    Transplantation; 2012 Sep; 94(6):603-11. PubMed ID: 22932115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basiliximab induction in renal transplantation: long-term outcome.
    Atlani M; Sharma RK; Gupta A
    Saudi J Kidney Dis Transpl; 2013 May; 24(3):473-9. PubMed ID: 23640617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients.
    Chisholm-Burns MA; Spivey CA; Rehfeld R; Zawaideh M; Roe DJ; Gruessner R
    Am J Transplant; 2009 Nov; 9(11):2497-504. PubMed ID: 19681814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penny wise, pound foolish? Coverage limits on immunosuppression after kidney transplantation.
    Gill JS; Tonelli M
    N Engl J Med; 2012 Feb; 366(7):586-9. PubMed ID: 22296029
    [No Abstract]   [Full Text] [Related]  

  • 28. Overall Graft Loss Versus Death-Censored Graft Loss: Unmasking the Magnitude of Racial Disparities in Outcomes Among US Kidney Transplant Recipients.
    Taber DJ; Gebregziabher M; Payne EH; Srinivas T; Baliga PK; Egede LE
    Transplantation; 2017 Feb; 101(2):402-410. PubMed ID: 26901080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health insurance considerations for adolescent transplant recipients as they transition to adulthood.
    Willoughby LM; Fukami S; Bunnapradist S; Gavard JA; Lentine KL; Hardinger KL; Burroughs TE; Takemoto SK; Schnitzler MA
    Pediatr Transplant; 2007 Mar; 11(2):127-31. PubMed ID: 17300489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of kidney transplantation in HIV-infected recipients.
    Stock PG; Barin B; Murphy B; Hanto D; Diego JM; Light J; Davis C; Blumberg E; Simon D; Subramanian A; Millis JM; Lyon GM; Brayman K; Slakey D; Shapiro R; Melancon J; Jacobson JM; Stosor V; Olson JL; Stablein DM; Roland ME
    N Engl J Med; 2010 Nov; 363(21):2004-14. PubMed ID: 21083386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graft survival of pediatric kidney transplant recipients selected for de novo steroid avoidance-a propensity score-matched study.
    Nehus EJ; Liu C; Lu B; Macaluso M; Kim MO
    Nephrol Dial Transplant; 2017 Aug; 32(8):1424-1431. PubMed ID: 28810723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extending Medicare immunosuppressive medication coverage.
    Beaubrun AC
    J Health Care Poor Underserved; 2012 Feb; 23(1):20-7. PubMed ID: 22643460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Markov modeling for evaluating the cost-effectiveness of immunosuppressive therapies in renal transplant recipients.
    Lewis RL; Canafax DM; Pettit KG; DiCesare J; Kaniecki DJ; Arnold RJ; Roberts MS
    Transplant Proc; 1996 Aug; 28(4):2214-7. PubMed ID: 8769203
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
    Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM
    Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes for kidney transplants at the National University Health System: comparison with overseas transplants.
    Vathsala A
    Clin Transpl; 2010; ():149-60. PubMed ID: 21696038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between loss of Medicare, immunosuppressive medication use, and kidney transplant outcomes.
    Hart A; Gustafson SK; Wey A; Salkowski N; Snyder JJ; Kasiske BL; Israni AK
    Am J Transplant; 2019 Jul; 19(7):1964-1971. PubMed ID: 30838768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents.
    Whitson BA; Kilic A; Lehman A; Wehr A; Hasan A; Haas G; Hayes D; Sai-Sudhakar CB; Higgins RS
    Clin Transplant; 2015 Jan; 29(1):9-17. PubMed ID: 25284138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective OKT3 induction therapy in adult cadaveric-donor renal transplant recipients.
    Thistlethwaite JR; Heffron TG; Stuart JK; Buckingham M; Stuart FP
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):28-34. PubMed ID: 2510508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tacrolimus versus cyclosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses.
    Lazzaro C; McKechnie T; McKenna M
    J Nephrol; 2002; 15(5):580-8. PubMed ID: 12455727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.